SCHEMBL3970946

SCHEMBL3970946

Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.62
NT5E P21589 1/20 0.62
HIF1A Q16665 1/20 0.62
ADORA2A P29274 4/20 0.62
ADORA3 P0DMS8 4/20 0.62
ADORA2B P29275 3/20 0.61
CYP2C19 P33261 1/20 0.60
HPGD P15428 1/20 0.60
ADORA1 P30542 2/20 0.60
SLC29A1 Q99808 2/20 0.60
DPP4 P27487 1/20 0.60
MEN1 O00255 1/20 0.60
SLC28A1 O00337 1/20 0.60
MAP3K7 O43318 1/20 0.60
SLC28A2 O43868 1/20 0.60
GAPDH P04406 1/20 0.60
MAPK1 P28482 1/20 0.60
STAT6 P42226 1/20 0.60
PI4KA P42356 1/20 0.60
KMT2A Q03164 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014081 0.89 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL899617 0.89 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL5033515 0.89 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL6663083 0.89 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL16555404 0.89 LMNA (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL343478 0.88 CYP2C19 (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL2424283 0.88 LMNA (0.64) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL62505 0.88 CYP2C19 (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL7535713 0.88 HPGD (0.62) LMNANT5EHIF1AADORA2AADORA3
SCHEMBL14931005 0.88 CYP2C19 (0.62) LMNANT5EHIF1AADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125630-A1 METHOD FOR BIOPROTAC DESIGN MEDIMMUNE LIMITED (GB) 2025-06-19 WO disclosed
WO-2023222116-A1 USE OF STEROID COMPOUND 广州润尔眼科生物科技有限公司 2023-11-23 WO disclosed
WO-2023089151-A1 MATERIALS AND METHODS FOR TREATMENT OF MACULAR DEGENERATION THE UNIVERSITY OF BRISTOL (GB) 2023-05-25 WO disclosed
EP-3990141-A1 COATINGS WITH IMMOBILIZED AFFINITY LIGANDS AND ENZYMES AND USE THEREOF IN LIQUID CHROMATOGRAPHY ASSAYS Waters Technologies Corporation (US) 2022-05-04 EP disclosed
CN-114041052-A Coating with immobilized affinity ligand and enzyme and use thereof in liquid chromatography assays 沃特世科技公司 2022-02-11 CN disclosed
US-20200406252-A1 COATINGS WITH IMMOBILIZED AFFINITY LIGANDS AND ENZYMES AND USE THEREOF IN LIQUID CHROMATOGRAPHY ASSAYS WATERS TECHNOLOGIES CORPORATION (US) 2020-12-31 US disclosed
WO-2020261221-A1 COATINGS WITH IMMOBILIZED AFFINITY LIGANDS AND ENZYMES AND USE THEREOF IN LIQUID CHROMATOGRAPHY ASSAYS WATERS TECHNOLOGIES CORPORATION (US) 2020-12-30 WO disclosed
WO-2020186187-A1 METHODS FOR TREATING BLADDER AND URETHRA DYSFUNCTION AND DISEASE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2020-09-17 WO disclosed
US-20200209230-A1 METHODS AND COMPOSITIONS RELATING TO SMALL MOLECULE ANALYTE ASSAYS ARBOR ASSAYS LLC 2020-07-02 US disclosed
CN-110023752-A Diagnosis, prognosis and treatment of schizophrenia and schizoaffective disorders 精密医药控股私人有限公司 2019-07-16 CN disclosed
US-20170370919-A1 METHODS AND COMPOSITIONS RELATING TO SMALL MOLECULE ANALYTE ASSAYS ARBOR ASSAYS LLC 2017-12-28 US disclosed
WO-2009043096-A1 IMPROVED METHOD FOR MUTAGENESIS ARANA THERAPEUTICS (VIC) PTY LTD (AU) 2009-04-09 WO disclosed